Compound Profile: Suprax Eczacibasi
Suprax Eczacibasi is a cephalosporin antibiotic preparation containing cefixime as the active pharmaceutical ingredient, specifically formulated for laboratory research applications. This third-generation cephalosporin demonstrates broad-spectrum antimicrobial activity against both gram-positive and gram-negative bacterial strains in microbiological studies. Researchers at Stroid UK Shop frequently utilise this compound to investigate beta-lactam resistance mechanisms, minimum inhibitory concentration determinations, and bacterial susceptibility testing protocols. The preparation offers standardised potency for reproducible experimental conditions in antimicrobial research settings.
Laboratory Applications
Research applications for Suprax Eczacibasi encompass extensive microbiological investigations, including bacterial resistance pattern analysis, biofilm formation studies, and antimicrobial efficacy assessments. Scientists examine this compound’s interaction with penicillin-binding proteins in bacterial cell wall synthesis research, contributing to understanding of beta-lactam antibiotic mechanisms. The preparation serves as a reference standard in comparative antimicrobial studies alongside other cefixime research compounds for comprehensive bacterial resistance profiling. Pharmaceutical researchers analyse its stability characteristics under various storage conditions to optimise formulation development protocols. Additionally, the compound facilitates investigations into bacterial enzyme production and their effects on cephalosporin degradation pathways in controlled laboratory environments.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Ingredient | Cefixime |
| Manufacturer | Eczacibasi |
| Form | Pharmaceutical preparation |
| Purity | Pharmaceutical grade |
| CAS Number | Verify with supplier |
| Storage | Room temperature, dry conditions |
| Shelf Life | As per manufacturer specifications |
This research-grade preparation maintains consistent quality standards for reliable experimental outcomes. Storage requirements follow pharmaceutical guidelines to preserve compound stability throughout research periods. Researchers should verify specific analytical data with supplier documentation before initiating studies.
Research Integration
Suprax Eczacibasi integrates effectively with broader antimicrobial research programmes investigating bacterial resistance mechanisms and therapeutic development pathways. The compound complements studies examining other pharmaceutical classes available through specialised research suppliers, including selective androgen receptor modulators and research peptides for comprehensive biological system investigations. Microbiological laboratories utilise this preparation alongside standard bacterial strains to establish baseline antimicrobial activity profiles and resistance threshold determinations. The pharmaceutical-grade formulation ensures reproducible results across multiple experimental sessions and research protocols. Scientists conducting longitudinal bacterial evolution studies employ this compound to track resistance development patterns over extended observation periods. This product is intended strictly for in-vitro laboratory research purposes only and is not approved for human consumption, therapeutic use, or any application outside controlled research environments.
